The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PRIME-HCC: Phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma.
 
David James Pinato
Honoraria - Bristol-Myers Squibb; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Da Volterra; Eisai; H3 Biomedicine; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline (Inst); MSD Oncology
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology
 
Alessio Cortellini
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Novartis; Roche
Speakers' Bureau - Astellas Pharma; AstraZeneca; MSD
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Novartis; Roche; Sanofi
 
Madhava Pai
No Relationships to Disclose
 
Duncan Spalding
No Relationships to Disclose
 
Thomas Talbot
No Relationships to Disclose
 
Robert D. Goldin
No Relationships to Disclose
 
Aneta Gupta
No Relationships to Disclose
 
Tom Cole
No Relationships to Disclose
 
Caroline Ward
No Relationships to Disclose
 
Vincent S. Yip
No Relationships to Disclose
 
Tony Singh Dhillon
No Relationships to Disclose
 
Sarah Slater
Consulting or Advisory Role - Eisai
 
Mikael Sodergren
No Relationships to Disclose
 
Paul Tait
Consulting or Advisory Role - Sirtex medical; Sirtex medical
Travel, Accommodations, Expenses - Sirtex medical
 
Nagy A. Habib
Employment - MINA THERAPEUTICS
Leadership - MINA THERAPEUTICS
Stock and Other Ownership Interests - MINA THERAPEUTICS
Consulting or Advisory Role - MINA THERAPEUTICS
Research Funding - MINA THERAPEUTICS
Travel, Accommodations, Expenses - MINA THERAPEUTICS
Other Relationship - Apterna
 
Robert Thomas
No Relationships to Disclose
 
Rohini Sharma
No Relationships to Disclose